logo

ADXN

Addex Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.34 / 10
Outperform

Capital flow analysis reveals a positive sentiment (score 7.34/10). All flow categories—overall, block, small, large, and extra-large—exhibit net inflow trends, with the medium category being the only one showing a slight negative bias. This robust liquidity inflow may cushion price declines and support potential rebounds, providing a silver lining against the otherwise weak fundamental and technical backdrop.

FundamentalSentiment(7.34)Technical
Fund Flow Rating
What is the analyst consensus for ADXN?
  • ADXN holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.34/10 (Outperform).